Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  isotretinoin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 107 for your search:
Start Over
Phase III Randomized Study of IFN-A with vs without 13-CRA in Patients with Metastatic Renal Cell Carcinoma (Summary Last Modified 02/96)
Phase: Phase III
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: MSKCC-94004, E-2894, NCI-T93-0198D, T93-0198
Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: EORTC-30951, NCT00002737
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 30 and under
Sponsor: NCI, Other
Protocol IDs: A3973, COG-A3973, CCG-A3973, POG-A3973, CCG-39703, FHCRC-1631.00, CDR0000067429, NCT00004188
Phase III Randomized Trial of Low-Dose ARA-C vs cis-Retinoic Acid in Preleukemia, ANLL, and CML
Phase: Phase III
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: UCCRC-3723, ICC-82L4, NCI-V83-0135
Phase III Randomized Evaluation of Isotretinoin for the Prevention of Basal Cell Carcinoma in a High-Risk Population (Summary Last Modified 08/88)
Phase: Phase III
Type: Prevention
Status: Closed
Age: 40 to 75
Sponsor:
Protocol IDs: DCPC-CPSB-10305
Phase III Study of 13-cis-Retinoic Acid vs Placebo for the Prevention of Skin Cancer in Patients with a History of Actinic Keratoses (Summary Last Modified 10/89)
Phase: Phase III
Type: Prevention
Status: Closed
Age: 21 to less than 85
Sponsor:
Protocol IDs: UARIZ-CA34256, NCI-P89-0004
Phase III Chemoprevention Study of Low-Dose 13-Cis-Retinoic Acid for Second Primary Tumors in Patients with Head and Neck Cancer
Phase: Phase III
Type: Prevention
Status: Completed
Age: 18 to 74
Sponsor: NCI
Protocol IDs: RTOG-9115, CLB-9499, SWOG-9446, MDA-CCOP-DM-90094, NCI-P91-0024, NCI-C91-0002, RTOG-91-15, MDA-C91-0002
Phase III, Double-Blind, Randomized Trial of 13-CRA vs Placebo to Prevent Second Primary Tumors in Patients with Totally Resected Stage I non-Small Cell Lung Cancer
Phase: Phase III
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MDA-ID-91025, CLB-9293, E-91025, NCCTG-912452, RTOG-9101, SWOG-9221, I91-0001, INT-0125, NCI-P92-0014
Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000271174, ECOG-1301, E1301, NCT00054561
High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas
Phase: Phase III
Type: Treatment
Status: Completed
Age: Under 21 at diagnosis
Sponsor: NCI, Other
Protocol IDs: ACNS0231, COG-ACNS0231, CDR0000353207, NCI-2012-02578, U10CA098543, NCT00078988
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Temporarily closed
Age: 3 to 21
Sponsor: NCI, Other
Protocol IDs: ACNS0332, NCI-2009-00336, COG-ACNS0332, CDR0000511991, R01CA114567, U10CA180886, U10CA098543, NCT00392327
Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
Phase: Phase III
Type: Treatment
Status: Closed
Age: 12 and under
Sponsor: NCI, Other
Protocol IDs: ANBL0531, COG-ANBL0531, CDR0000554708, NCI-2009-00400, NCT00499616
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 30 and under
Sponsor: NCI, Other
Protocol IDs: ANBL0532, NCI-2009-01065, CDR0000576571, COG-ANBL0532, U10CA098543, NCT00567567
Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Any age
Sponsor: NCI
Protocol IDs: NCI-2011-01997, COG-ANBL0931, CDR0000662673, ANBL0931, U10CA098543, NCT01041638
Phase I/II Study of IFN-A/13-CRA plus Radiotherapy for Newly Diagnosed High-Grade Gliomas (Summary Last Modified 12/98)
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: Other
Protocol IDs: CBRG-9508, NBSG-9508, NCI-V96-0834
Phase I/II Study of Chemopreventive Agents for the Prevention of Skin Cancer (Summary Last Modified 04/1999)
Phase: Phase II, Phase I
Type: Prevention
Status: Completed
Age: 50-84
Sponsor: NCI
Protocol IDs: MDA-ID-95184, NCI-P97-0099
Start Over